| Literature DB >> 30400221 |
Chia-Chi Wang1, Chu-Chun Fang2,3, Ying-Hsian Lee4, Ming-Ta Yang5, Kuei-Hui Chan6.
Abstract
Creatine supplementation has an ergogenic effect in an acute complex training bout, but the benefits of chronic creatine supplementation during long-term complex training remain unknown. The study aimed to evaluate the effects of 4-week complex training combined with creatine supplementation on sport performances and muscle damage biomarkers. Thirty explosive athletes were assigned to the creatine or placebo group, which consumed 20 g of creatine or carboxymethyl cellulose, respectively, per day for 6 days followed by 2 g of the supplements until the end of the study. After 6 days of supplementation, subjects performed tests of one repetition maximum (1-RM) strength of half squat and complex training bouts to determine the optimal individual post-activation potentiation time. Thereafter, all subjects performed a complex training programme consisting of six sets of 5-RM half squats and plyometric jumps 3 times per week for 4 weeks. Body composition, 30-m sprint and jump performances were assessed before and after the training period. Moreover, blood creatine kinase (CK) activity was analysed at the first and the last training bout. After the training, the 1-RM strength in the creatine group was significantly greater than in the placebo group (p < 0.05). CK activity after the complex training bout in the creatine group was significantly reduced compared with the placebo group (p < 0.05). No differences were noted for other variables. This study concluded that creatine supplementation combined with complex training improved maximal muscular strength and reduced muscle damage during training.Entities:
Keywords: creatine kinase; half squat; optimal individual post-activation potentiation time; plyometric jump
Mesh:
Substances:
Year: 2018 PMID: 30400221 PMCID: PMC6265971 DOI: 10.3390/nu10111640
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Subject characteristics.
| Variable | Creatine Group | Placebo Group |
|---|---|---|
| Height (cm) | 171.93 ± 4.86 | 175.93 ± 8.49 |
| Weight (kg) | 67.86 ± 6.72 | 70.21 ± 11.16 |
| Age (years) | 20 ± 2 | 20 ± 1 |
Data are mean ± standard deviation (SD), n = 15 in each group.
Complex training protocol.
| Set | Heavy Resistance Exercise | Recovery Time | Plyometric Training | ||
|---|---|---|---|---|---|
| Mode | Load | Rest Time | Mode | Repetitions | |
| 1 | Half squat | 5-RM | Optimal individual PAP time | Vertical jump | 8 |
| 4 min | |||||
| 2 | Half squat | 5-RM | Optimal individual PAP time | Squat jump | 8 |
| 4 min | |||||
| 3 | Half squat | 5-RM | Optimal individual PAP time | Vertical jump | 8 |
| 4 min | |||||
| 4 | Half squat | 5-RM | Optimal individual PAP time | Squat jump | 8 |
| 4 min | |||||
| 5 | Half Squat | 5-RM | Optimal individual PAP time | Vertical jump | 8 |
| 4 min | |||||
| 6 | Half squat | 5-RM | Optimal individual PAP time | Squat jump | 8 |
RM = repetition maximum; PAP = post-activation potentiation.
Body composition and sport performances in the creatine and placebo groups after 4 weeks of complex training.
| Variable | Creatine Group | Placebo Group | ||
|---|---|---|---|---|
| Pre-Training | Post-Training | Pre-Training | Post-Training | |
| Body mass (kg) | 67.87 ± 6.72 (63.00–72.75) | 68.51 ± 6.50 (63.79–73.24) | 70.21 ± 11.16 (65.34–75.09) | 70.34 ± 10.82 (65.62–75.06) |
| Body fat (%) a | 15.78 ± 4.18 (13.52–18.05) | 13.77 ± 4.01 (11.87–15.68) | 13.67 ± 4.37 (11.87–15.68) | 12.76 ± 3.13 (10.86–14.67) |
| Fat-free mass (kg) | 57.07 ± 4.84 (53.06–61.08) | 58.97 ± 5.18 (55.03–62.91) | 60.47 ± 9.55 (56.46–64.48) | 61.58 ± 9.17 (57.64–65.52) |
| 30 m sprint (second) | 4.33 ± 0.20 (4.21–4.43) | 4.14 ± 0.18 # (4.05–4.23) | 4.27 ± 0.21 (4.16–4.38) | 4.19 ± 0.16 # (4.10–4.28) |
| Half squat 1-RM (kg) | 133.67 ± 14.07 (125.76–141.573) | 178.33 ± 16.86 #,* (169.99–186.68) | 131.67 ± 15.77 (123.76–139.57) | 165.66 ± 14.62 # (157.32–174.02) |
| Jump height (cm) a | 45.60 ± 5.18 (42.63–48.58) | 54.60 ± 5.95 (51.63–57.59) | 46.99 ± 6.04 (44.02–49.97) | 53.93 ± 5.29 (50.96–56.91) |
| Jump peak power (W) a | 3729.40 ± 474.54 (3446.08–4012.72) | 4166.52 ± 466.87 (3868.38−4464.66) | 3903.41 ± 635.71 (3620.10–4186.73) | 4260.44 ± 646.17 (3962.30–4558.58) |
Data are mean ± SD (95% confidence interval (CI)). n = 15 in each group. # Indicates a significant difference (p < 0.05) from the pre-training value within the group. * Indicates a significant difference (p < 0.05) from the placebo group at the same training time. a Indicates a significant time main effect (p < 0.05).
Figure 1Creatine kinase activity in the creatine and placebo groups after (A) the first and (B) last training bouts. All values after training were significantly increased compared with pre-training values in both groups (p < 0.05). * Indicates a significant difference (p < 0.05) from the placebo group at the same time point.